Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

4 results

  • Chapter 13 - Artificial Insemination with Partner’s Sperm for Male Subfertility

  • Edited by R. John Aitken, University of Newcastle, New South Wales, David Mortimer, Gabor Kovacs
  • Book: Male and Sperm Factors that Maximize IVF Success
  • Published online: 24 May 2020
  • Print publication: 30 April 2020, pp 154-165

  • Summary

    According to a number of high-quality studies, intrauterine insemination (IUI) with homologous semen should be the first choice of treatment in the case of moderate male factor subfertility. IVF and ICSI are clearly over-used in this selected group of infertile couples. The limited value of IUI in infertility treatment, as mentioned in the 2013 NICE guidelines, was surely a premature statement and should be adapted to the actual literature. Oxidative stress and high sperm DNA damage is associated with lower pregnancy rates after IUI. Concerning clinical outcome, there is no clear evidence of any sperm preparation technique to be superior. More evidence-based data are becoming available on different variables influencing the success rates after IUI. It can be expected that these findings may lead to a better understanding and use of IUI in the near future.

  • Chapter 12 - Intrauterine insemination – who should be treated and what are the expectations?

  • from Section 2 - The role of AIH before IVF
  • Edited by Gab Kovacs, Monash University, Victoria
  • Book: How to Improve your ART Success Rates
  • Published online: 05 July 2011
  • Print publication: 30 June 2011, pp 63-66

  • Summary

    Intrauterine insemination (IUI) aims to bypass the cervical-mucus barrier and to increase the number of motile spermatozoa with a high proportion of normal forms at the site of fertilization, as close as possible to the oocytes. In most cases of cervical hostility, unexplained and moderate male infertility, expectant management and timed intercourse (TI) in natural cycles are the first choice option. When unsuccessful, IUI can be promoted as the best first-line treatment in most cases of subfertility provided at least one tube is patent and an inseminating motile count (IMC) of more than 1 million can be obtained after sperm preparation. In a selected group of patients it is unwise to start with assisted reproductive techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) since these techniques are more invasive and less cost-effective.